Positive Minimal Residual Disease By Multiparameter Flow Cytometry in 9 Months after Autologous Stem Cell Transplantation and High-Risk Cytogenetics Predict Poor Outcome in Multiple Myeloma

被引：0
|
作者：
Huang, Beihui
Li, Juan
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4532
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Abnormal cytogenetics predict for poor survival after peripheral blood stem cell transplantation in relapsed multiple myeloma.
    Rajkumar, SV
    Fonseca, R
    Lacy, MQ
    Witzig, TE
    Lust, JA
    Griepp, PR
    Kyle, RA
    Litzow, MR
    Gertz, MA
    BLOOD, 1997, 90 (10) : 2348 - 2348
  • [42] Multiparameter Flow Cytometry Remission Is the Most Relevant Prognostic Factor for Multiple Myeloma Patients Who Undergo Autologous Stem Cell Transplantation
    Paiva, Bruno
    Vidriales, Maria-Belen
    Cervero, Jorge
    Mateo, Gema
    Perez, Jose J.
    Angeles Montalban, Maria
    Sureda, Anna
    Montejano, Laura
    Gutierrez, Norma C.
    Garcia de Coca, Alfonso
    de Ias Heras, Natalia
    Victoria Mateos, Maria
    Lopez-Berges, Maria-Consuelo
    Garcia-Boyero, Raimundo
    Galende, Josefina
    Hernandez, Jose
    Palomera, Luis
    Carrera, Dolores
    Martinez, Rafael
    De la Rubia, Javier
    Martin, Alejandro
    Blade, Joan
    Jose Lahuerta, Juan
    Orfao, Alberto
    San Miguel, J. F.
    BLOOD, 2008, 112 (11) : 273 - 274
  • [43] Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
    Liu, Jiahui
    Yan, Wenqiang
    Fan, Huishou
    Xu, Jingyu
    Li, Lingna
    Du, Chenxing
    Mao, Xuehan
    Yan, Yuting
    Xu, Yan
    Sui, Weiwei
    Deng, Shuhui
    Yi, Shuhua
    Anderson, Kenneth C.
    Qiu, Lugui
    Zou, Dehui
    An, Gang
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (09): : 1770 - 1780
  • [44] Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma
    Pasvolsky, Oren
    Milton, Denai R.
    Rauf, Mikael
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Tang, Guilin
    Saini, Neeraj
    Ramdial, Jeremy
    Masood, Adeel
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (11): : 752.e1 - 752.e6
  • [45] Minimal residual disease (MRD) ratio before and after autologous stem cells transplantation (ASCT) in multiple myeloma (MM)
    Boncompagni, Riccardo
    Staderini, Michela
    Nozzoli, Chiara
    Antonioli, Elisabetta
    Accogli, Barbara
    Saccardi, Riccardo
    BONE MARROW TRANSPLANTATION, 2019, 54 : 121 - 122
  • [46] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma
    Murakami, H
    Fujii, H
    Inaba, T
    Shimazaki, C
    Okamoto, S
    Miwa, A
    Sawamura, M
    Abe, M
    Chou, T
    Asaoku, H
    Kitahara, Y
    Hayashi, K
    Kosaka, M
    Togawa, A
    Takatsuki, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (03) : 169 - 173
  • [47] ERADICATION OF MINIMAL RESIDUAL DISEASE, ANALYZED BY PCR, AFTER DOUBLE HIGH-DOSE CHEMORADIOTHERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
    BJORKSTRAND, B
    LJUNGMAN, P
    BIRD, JM
    SAMSON, D
    GAHRTON, G
    BLOOD, 1994, 84 (10) : A208 - A208
  • [48] High-nose chemotherapy in multiple myeloma (MM): Analysis of minimal residual disease after autologous or allogeneic blood cell transplantation
    Corradini, P
    Astolfi, M
    Voena, C
    Ladetto, M
    Tarella, C
    Boccadoro, M
    Pileri, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 944 - 944
  • [49] Pre-Transplant M Protein Level Predicts Minimal Residual Disease Status after Autologous Stem Cell Transplantation in Multiple Myeloma
    Meyer, Zachary S.
    Manaa, Mohamed
    Han, Yan
    Czader, Magdalena
    Suvannasankha, Attaya
    Abonour, Rafat
    Farag, Sherif S.
    Stanley, Melissa
    Abu Zaid, Mohammad Issam
    BLOOD, 2021, 138
  • [50] The Value of Minimal Residual Disease as a Progression-Free Survival Predictor After Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients
    Solovev, Maxim
    Mendeleeva, Larisa
    Firsova, Maiia
    Julhakyan, Hunan
    Galtseva, Irina
    Davydova, Julia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S324 - S324
12345